Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,297 | 127,598 | 126,003 | 98,165 | 97,045 |
| Marketable Securities | 265,593 | 110,250 | 119,658 | 188,912 | 238,474 |
| TOTAL | $397,244 | $245,008 | $252,884 | $296,472 | $341,528 |
| Non-Current Assets | |||||
| PPE Net | 5,274 | 5,850 | 6,453 | 6,467 | 7,017 |
| Investments And Advances | 0 | 0 | 0 | 0 | 10,029 |
| Other Non-Current Assets | 23,415 | 23,959 | 24,461 | 24,959 | 25,442 |
| TOTAL | $28,689 | $29,809 | $30,914 | $31,426 | $42,488 |
| Total Assets | $425,933 | $274,817 | $283,798 | $327,898 | $384,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,029 | 16,625 | 14,154 | 12,013 | 15,061 |
| Accrued Expenses | 44,511 | 40,139 | 33,553 | 42,132 | 36,467 |
| TOTAL | $62,246 | $58,422 | $49,318 | $55,710 | $53,048 |
| Non-Current Liabilities | |||||
| Long Term Debt | 44,250 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 16,973 | 17,410 | 15,485 | 15,902 | 16,309 |
| TOTAL | $61,223 | $61,359 | $15,485 | $15,902 | $16,309 |
| Total Liabilities | $123,469 | $119,781 | $64,803 | $71,612 | $69,357 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 142,377 | 139,701 | 113,857 | 113,850 | 110,462 |
| Common Shares | 141 | 114 | 114 | 110 | 110 |
| Retained earnings | -1,085,928 | -1,004,998 | -931,469 | -859,483 | -791,556 |
| Other shareholders' equity | 108,123 | 107,928 | 108,329 | 111,047 | 111,496 |
| TOTAL | $302,464 | $155,036 | $218,995 | $256,286 | $314,659 |
| Total Liabilities And Equity | $425,933 | $274,817 | $283,798 | $327,898 | $384,016 |